PRFX
PRF Technologies Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$1.02
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 0.05x
- P/S forward
- 152.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.22x
- Price / sales
- 90.36x
- Price / cash flow
- -0.48x
Enterprise value
- Enterprise value
- -$7.3M
- EV / sales
- -185.16x
- EV / EBITDA
- 0.99x
- EV / EBIT
- 0.81x
- Market cap
- $3.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026